Mid Ohio Oncology/Hematology Inc. ( Site 0003) — Columbus, Ohio

Mid Ohio Oncology/Hematology Inc. ( Site 0003) is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mid Ohio Oncology/Hematology Inc. ( Site 0003) has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Ohio Oncology/Hematology Inc. ( Site 0003)?

Mid Ohio Oncology/Hematology Inc. ( Site 0003) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Ohio Oncology/Hematology Inc. ( Site 0003) conducted?

Mid Ohio Oncology/Hematology Inc. ( Site 0003) has 1 clinical trials on record. Their work covers Carcinoma, Non-Small-Cell Lung.

Is Mid Ohio Oncology/Hematology Inc. ( Site 0003) accredited by Crixeo Health?

Mid Ohio Oncology/Hematology Inc. ( Site 0003) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Ohio Oncology/Hematology Inc. ( Site 0003)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.